Laboratory studies in pediatric bone and joint infections;Marqueurs de l'inflammation et infection ostéoarticulaire

Archives de Pediatrie

Volumn 14, Issue SUPPL. 2, 2007, Pages

  Lorrot, M ^a   Fitoussi, F ^a   Faye, A ^a   Mariani, P ^a   Job Deslandre, C ^b   Pennecot G F ^a   Bingen, E ^a   Bourrillon, A ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b HôpitaI Robert Debré ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; PROCALCITONIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL ARTHRITIS; BONE INFECTION; CHILDHOOD DISEASE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; INFECTIOUS ARTHRITIS; LABORATORY DIAGNOSIS; LEUKOCYTE COUNT; OSTEOMYELITIS; PREDICTION; RELIABILITY; SURGICAL DRAINAGE; TREATMENT RESPONSE;

EID: 35348847540     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(07)80040-6     Document Type: Article

References (30)

1. Gavilan M., Lopez J., and Artola B. Peculiarities of osteo-articular infections in children. Baillieres Best Pract Res Clin Rheumatol 13 (1999) 77-94
2. Carek P., Dickerson L., and Sack J. Diagnosis and management of osteomyelitis. Am Fam Physician 63 (2001) 2413-2420
3. Glorion C. Pathologies infectieuses du système ostéo-articulaire. Rhumatologie pédiatrique sous la direction d'A.M. Prieur. Flammarion (1999), Médecine-Sciences, Paris 291-305
4. Dirschl D., and Almekinders L. Osteomyelitis. Common causes and treatment recommendations. Drugs 45 (1993) 29-43
5. Gutierrez K. Bone and joint infections in children. Pediatr Clin North Am 52 (2005) 779-794
6. Rosey A., Abachin E., Quesnes G., et al. Development of a broad-range 16S rDNA real-time PCR for the diagnosis of septic arthritis in children. J Microbiol Methods 68 (2007) 88-93
7. O'Brien T., McManus F., MacAuley P., et al. Acute haematogenous osteomyelitis. J Bone Joint Surg Br 64 (1982) 450-453
8. Zlonis M. The mystique of the erythrocyte sedimentation rate. A reappraisal of one of the oldest laboratory tests still in use. Clin Lab Med. 13 (1993) 787-800
9. Morrey B., and Peterson H. Hematogenous pyogenic osteomyelitis in children. Orthop Clin North Am. 6 (1975) 935-951
10. Faden H., and Grossi M. Acute osteomyelitis in children. Reassessment of etiologic agents and their clinical characteristics. Am J Dis Child 145 (1991) 65-69
11. Dich V., Nelson J., and Haltalin K. Osteomyelitis in infants and children. A review of 163 cases. Am J Dis Child 129 (1975) 1273-1278
12. Unkila-Kallio L., Kallio M., Eskola J., et al. Serum C-reactive protein, erythrocyte sedimentation rate, and white blood cell count in acute hematogenous osteomyelitis of children. Pediatrics. 93 (1994) 59-62
13. Timsit S., Pannier S., Glorion C., et al. Ostéomyé1ite aiguë et arthrite sceptique chez l'enfant : un an d'expErience. Arch Pediatr 12 (2005) 16-22
14. Del Beccaro M., Champoux A., Bockers T., et al. Septic arthritis versus transient synovitis of the hip:the value of screening laboratory tests. Ann Emerg Med 21 (1992) 1418-1422
15. Jung S., Rowe S., Moon E., et al. Significance of laboratory and radiologic findings for differentiating between septic arthritis and transient synovitis of the hip. J Pediatr Orthop 23 (2003) 368-372
16. Kocher M., Mandiga R., Murphy J., et al. A clinical practice guideline for treatment of septic arthritis in children:efficacy in improving process of care and effect on outcome of septic arthritis of the hip. J Bone Joint Surg Am 85-A 6 (2003) 994-999
17. Kocher M., Mandiga R., Zurakowski D., et al. Validation of a clinical prediction rule for the differentiation between septic arthritis and transient synovitis of the hip in children. J Bone Joint Surg Am 86-A 8 (2004) 1629-1635
18. Jaye D., and Waites K. Clinical applications of C-reactive protein in pediatrics. Pediatr Infect Dis J. 16 (1997) 735-746
19. Unkila-Kallio L., Kallio M., and Peltola H. The usefulness of C-reactive protein levels in the identification of concurrent septic arthritis in children who have acute hematogenous osteomyelitis. A comparison with the usefulness of the erythrocyte sedimentation rate and the white blood-cell count. J Bone Joint Surg Am 76 (1994) 848-853
20. Roine I., Faingezicht I., Arguedas A., et al. Serial serum C-reactive protein to monitor recovery from acute hematogenous osteomyelitis in children. Pediatr Infect Dis J 14 (1995) 40-44
21. Khachatourians A., Patzakis M., Roidis N., et al. Laboratory monitoring in pediatric acute osteomyelitis and septic arthritis. Clin Orthop Relat Res 409 (2003) 186-194
22. Levine M., McGuire K., McGowan K., et al. Assessment of the test characteristics of C-reactive protein for septic arthritis in children. J Pediatr Orthop. 23 (2003) 373
23. Caird M., Flynn J., Leung Y., et al. Factors distinguishing septic arthritis from transient synovitis of the hip in children. A prospective study. J Bone Joint Surg Am. 88 (2006) 1251-1257
24. Van Rossum A., Wulkan R., and Oudesluys-Murphy A. Procalcitonin as an early marker of infection in neonates and children. Lancet Infect Dis. 4 (2004) 620-630
25. Gendrel D., and Bohuon C. Procalcitonin as a marker of bacterial infection. Pediatr Infect Dis J. 19 (2000) 679-687
26. Martinot M., Sordet C., Soubrier M., et al. Diagnostic value of serum and synovial procalcitonin in acute arthritis:a prospective study of 42 patients. Clin Exp Rheumatol 23 (2005) 303-310
27. Butbul-Aviel Y., Koren A., Halevy R., et al. Procalcitonin as a diagnostic aid in osteomyelitis and septic arthritis. Pediatr Emerg Care 21 (2005) 828-832
28. Ibia E., Imoisili M., and Pikis A. Group A beta-hemolytic streptococcal osteomyelitis in children. Pediatrics. 112 1Pt 1 (2003) 22-26
29. Bocchini C., Hulten K., Mason Jr. E., et al. Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomyelitis in children. Pediatrics 117 (2006) 433-440
30. Yagupsky E. Kingella kingae: from medical rarity to an emerging paediatric pathogen. Lancet Infect Dis 4 (2004) 358-367